CATCH 2023 Meeting Summary: Collaborate & Address Treatment Challenges in Haemophilia

1. European Haemophilia Consortium. Haemophilia care in Europe: 2009-2018. Available from https://www.ehc.eu/haemophilia-care-in-europe/ (accessed December 2023). European Haemophilia Consortium . Haemophilia care in Europe: 2009-2018 . Available from https://www.ehc.eu/haemophilia-care-in-europe/ ( accessed December 2023 ). Search in Google Scholar

2. World Federation of Haemophilia. Report on the Annual Global Survey 2021. WFH, 2022. Available from https://www1.wfh.org/publications/files/pdf-2399.pdf (accessed December 2023). World Federation of Haemophilia . Report on the Annual Global Survey 2021 . WFH , 2022 . Available from https://www1.wfh.org/publications/files/pdf-2399.pdf ( accessed December 2023 ). Search in Google Scholar

3. Rayment R, Chalmers E, Forsyth K, et al.; British Society for Haematology. Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B. Br J Haematol 2020; 190(5): 684-695. doi: 10.1111/bjh.16704. Rayment R Chalmers E Forsyth K .; British Society for Haematology. Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B . Br J Haematol 2020 ; 190 ( 5 ): 684 - 695 . doi: 10.1111/bjh.16704 . Open DOISearch in Google Scholar

4. Chowdary P. Nonfactor therapies: new approaches to prophylactic treatment of haemophilia. Hamostaseologie 2021; 41(4): 247-256. doi: 10.105/a-1424-7900. Chowdary P. Nonfactor therapies: new approaches to prophylactic treatment of haemophilia . Hamostaseologie 2021 ; 41 ( 4 ): 247 - 256 . doi: 10.105/a-1424-7900 . Open DOISearch in Google Scholar

5. European Medicines Agency. First gene therapy to treat severe haemophilia A. Available from https://www.ema.europa.eu/en/news/first-gene-therapy-treat-severe-haemophilia (accessed December 2023). European Medicines Agency . First gene therapy to treat severe haemophilia A . Available from https://www.ema.europa.eu/en/news/first-gene-therapy-treat-severe-haemophilia ( accessed December 2023 ). Search in Google Scholar

6. European Medicines Agency. First gene therapy to treat severe haemophilia B. Available from https://www.ema.europa.eu/en/news/first-gene-therapy-treat-haemophilia-b (accessed December 2023). European Medicines Agency . First gene therapy to treat severe haemophilia B . Available from https://www.ema.europa.eu/en/news/first-gene-therapy-treat-haemophilia-b ( accessed December 2023 ). Search in Google Scholar

7. van Galen K, Lavin M, Skouw-Rasmussen N, et al.; European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD). European Principles of Care for Women and Girls with Inherited Bleeding Disorders. Haemophilia 2021; 27(5): 837-847. doi: 10.1111/hae.14379. van Galen K Lavin M Skouw-Rasmussen N European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD) . European Principles of Care for Women and Girls with Inherited Bleeding Disorders . Haemophilia 2021 ; 27 ( 5 ): 837 - 847 . doi: 10.1111/hae.14379 . Open DOISearch in Google Scholar

8. Lewandowska M, Nasr S, Shapiro A. Therapeutic and technological advancements in haemophilia care: Quantum leaps forward. Haemophilia 2022; 28 Suppl 4: 77-92. doi: 10.1111/hae.14531. Lewandowska M Nasr S Shapiro A. Therapeutic and technological advancements in haemophilia care: Quantum leaps forward . Haemophilia 2022 ; 28 Suppl 4: 77 - 92 . doi: 10.1111/hae.14531 . Open DOISearch in Google Scholar

9. Inherited and Acquired Haemophilia and other Bleeding Disorders Peer Review Programme. Overview Report. May 2020. Available from https://haemophilia.org.uk/wp-content/uploads/pdf/IABD-Overview-Report-2020-V1-20200514.pdf (accessed September 2023). Inherited and Acquired Haemophilia and other Bleeding Disorders Peer Review Programme. Overview Report . May 2020 . Available from https://haemophilia.org.uk/wp-content/uploads/pdf/IABD-Overview-Report-2020-V1-20200514.pdf ( accessed September 2023 ). Search in Google Scholar

10. Hughes T, Brok-Kristensen M, Gargeya Y, et al. “What more can we ask for?”: an ethnographic study of challenges and possibilities for people living with haemophilia. J Haem Pract 2020; 7(1): 25-36. doi: 10.17225/jhp00151. Hughes T Brok-Kristensen M Gargeya Y . “What more can we ask for?”: an ethnographic study of challenges and possibilities for people living with haemophilia . J Haem Pract 2020 ; 7 ( 1 ): 25 - 36 . doi: 10.17225/jhp00151 . Open DOISearch in Google Scholar

11. Hughes T, Brok-Kristensen M, Gargeya Y, et al. Treating for stability: an ethnographic study of aspirations and limitations in haemophilia treatment in Europe. J Haem Pract 2020; 7(1): 165-172. doi: 10.17225/jhp00169. Hughes T Brok-Kristensen M Gargeya Y . Treating for stability: an ethnographic study of aspirations and limitations in haemophilia treatment in Europe . J Haem Pract 2020 ; 7 ( 1 ): 165 - 172 . doi: 10.17225/jhp00169 . Open DOISearch in Google Scholar

12. Recht M, Konkle BA, Jackson E, et al. Recognising the need for personalisation of haemophilia patient-reported outcomes in the prophylaxis era. Haemophilia 2016; 22(6): 825-832. doi: 10.1111/hae.13066. Recht M Konkle BA Jackson E . Recognising the need for personalisation of haemophilia patient-reported outcomes in the prophylaxis era . Haemophilia 2016 ; 22 ( 6 ): 825 - 832 . doi: 10.1111/hae.13066 . Open DOISearch in Google Scholar

13. National Institute for Health and Care Research. Underserved communities. Available from https://www.nihr.ac.uk/about-us/our-key-priorities/under-served-communities.htm (accessed September 2023). National Institute for Health and Care Research . Underserved communities . Available from https://www.nihr.ac.uk/about-us/our-key-priorities/under-served-communities.htm ( accessed September 2023 ). Search in Google Scholar

14. Skinner MW, Dolan G, Eichler H, O’Mahony B; International Haemophilia Strategy Council. A preliminary application of a haemophilia value framework to emerging therapies in haemophilia. Haemophilia 2022; 28 Suppl 2: 9-18. doi: 10.1111/hae.14511. Skinner MW Dolan G Eichler H O’Mahony B International Haemophilia Strategy Council . A preliminary application of a haemophilia value framework to emerging therapies in haemophilia . Haemophilia 2022 ; 28 Suppl 2: 9 - 18 . doi: 10.1111/hae.14511 . Open DOISearch in Google Scholar

15. Hermans C, Noone D, Benson D, et al. Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev 2022; 52: 100890. doi: 10.1016/j.blre.2021.100890. Hermans C Noone D Benson D . Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians . Blood Rev 2022 ; 52 : 100890 . doi: 10.1016/j.blre.2021.100890 . Open DOISearch in Google Scholar

16. Hermans C, Kulkarni R. Women with bleeding disorders. Haemophilia 2018; 24 Suppl 6: 29-36. doi: 10.1111/hae.13502. Hermans C Kulkarni R. Women with bleeding disorders . Haemophilia 2018 ; 24 Suppl 6: 29 - 36 . doi: 10.1111/hae.13502 . Open DOISearch in Google Scholar

17. UKHCDO and NHD. UKHCDO Annual Report 2022 & Bleeding Disorder Statistics for the Financial Year 2021/2022. UKHCDO, 2022. Available from https://www.ukhcdo.org/wp-content/uploads/2022/12/UKHCDO-Annual-Report-2022-2021-22-Data.pdf (accessed September 2023). UKHCDO and NHD . UKHCDO Annual Report 2022 & Bleeding Disorder Statistics for the Financial Year 2021/2022 . UKHCDO , 2022 . Available from https://www.ukhcdo.org/wp-content/uploads/2022/12/UKHCDO-Annual-Report-2022-2021-22-Data.pdf ( accessed September 2023 ). Search in Google Scholar

18. Oxford Haemophilia Centre. Internal data provided by speaker. Oxford Haemophilia Centre . Internal data provided by speaker . Search in Google Scholar

19. Parker M, Hannah M, Zia A. “If I wasn’t a girl”: Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders. Res Pract Thromb Haemost 2022; 6(4): e12727. doi: 10.1002/rth2.12727. Parker M Hannah M Zia A. “If I wasn’t a girl”: Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders . Res Pract Thromb Haemost 2022 ; 6 ( 4 ) : e12727. doi: 10.1002/rth2.12727 . Open DOISearch in Google Scholar

20. Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022; 28(2): 316-325. doi: 10.1111/hae.14514. Khair K Pollard D Steadman L Jenner K Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study . Haemophilia 2022 ; 28 ( 2 ): 316 - 325 . doi: 10.1111/hae.14514 . Open DOISearch in Google Scholar

21. Chaigneau M, Botros M, Grabell J, Hopman W, James P. Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers. Res Pract Thromb Haemost 2022; 6(6): e12783. doi: 10.1002/rth2.12783. Chaigneau M Botros M Grabell J Hopman W James P. Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers . Res Pract Thromb Haemost 2022 ; 6 ( 6 ) : e12783. doi: 10.1002/rth2.12783 . Open DOISearch in Google Scholar

22. Noone D, Skouw-Rasmussen N, Lavin M, van Galen K, Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium. Haemophilia 2019; 25(3): 468-474. doi: 10.1111/13722. Noone D Skouw-Rasmussen N Lavin M van Galen K Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium . Haemophilia 2019 ; 25 ( 3 ): 468 - 474 . doi: 10.1111/13722 . Open DOISearch in Google Scholar

23. Whitaker S, Aiston H, Hung WT, Pink R, Mangles S. Haemophilia Carriers Experience Study (CARES): A mixed method exploration into the experience of women who are carriers of haemophilia. Haemophilia 2021; 27(5): 848-853. doi: 10.1111/hae.14360. Whitaker S Aiston H Hung WT Pink R Mangles S. Haemophilia Carriers Experience Study (CARES): A mixed method exploration into the experience of women who are carriers of haemophilia . Haemophilia 2021 ; 27 ( 5 ): 848 - 853 . doi: 10.1111/hae.14360 . Open DOISearch in Google Scholar

24. van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19(8): 1883-1887. doi: 10.1111/jth.15397. van Galen KPM d’Oiron R James P . A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH . J Thromb Haemost 2021 ; 19 ( 8 ): 1883 - 1887 . doi: 10.1111/jth.15397 . Open DOISearch in Google Scholar

25. Scott MJ, Xiang H, Hart DP, et al. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study. Haemophilia 2019; 25(2): 205-212. doi: 10.1111/hae.13616. Scott MJ Xiang H Hart DP . Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study . Haemophilia 2019 ; 25 ( 2 ): 205 - 212 . doi: 10.1111/hae.13616 . Open DOISearch in Google Scholar

26. Pulles AE, Mastbergen SC, Schutgens REG, Lafeber FPJG, van Vulpen LFD. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res 2017; 115: 192-199. doi: 10.1016/j,phrs.2016.11.032. Pulles AE Mastbergen SC Schutgens REG Lafeber FPJG van Vulpen LFD. Pathophysiology of hemophilic arthropathy and potential targets for therapy . Pharmacol Res 2017 ; 115 : 192 - 199 . doi: 10.1016/j,phrs.2016.11.032 . Open DOISearch in Google Scholar

27. Puetz J. Nano-evidence for joint microbleeds in hemophlia patients. J Thromb Haemost 2018; 16(10): 1914-1917. doi: 10.1111/jth.14242. Puetz J. Nano-evidence for joint microbleeds in hemophlia patients . J Thromb Haemost 2018 ; 16 ( 10 ): 1914 - 1917 . doi: 10.1111/jth.14242 . Open DOISearch in Google Scholar

28. Baud-huin M, Duplomb L, Téletchéa S, et al. Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. J Biol Chem 2009; 284(46): 31704-13. doi: 10.1074/jbc.M109.030312. Baud-huin M Duplomb L Téletchéa S . Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival . J Biol Chem 2009 ; 284 ( 46 ): 31704 - 13 . doi: 10.1074/jbc.M109.030312 . Open DOISearch in Google Scholar

29. Mackie EJ, Loh L-H, Sivagurunathan S, et al. Protease-activated receptors in the musculoskeletal system. Int J Biochem Cell Biol 2008; 40(6-7): 1169-84. doi: 10.1016/j.biocel.2007.12.003. Mackie EJ Loh L-H Sivagurunathan S . Protease-activated receptors in the musculoskeletal system . Int J Biochem Cell Biol 2008 ; 40 ( 6-7 ): 1169 - 84 . doi: 10.1016/j.biocel.2007.12.003 . Open DOISearch in Google Scholar

30. Gerstner G, Damiano ML, Tom A, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009; 15(2): 559-65. doi: 10.1111/j.1365-2516.2008.01963.x. Gerstner G Damiano ML Tom A . Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia . Haemophilia 2009 ; 15 ( 2 ): 559 - 65 . doi: 10.1111/j.1365-2516.2008.01963.x . Open DOISearch in Google Scholar

31. Tuan S-H, Hu L-Y, Sun S-F, et al. Risk of osteoporotic fractures as a consequence of haemophilia: A nationwide populationbased cohort study. Haemophilia 2019; 25(5): 876-884. doi: 10.1111/hae.13814. Tuan S-H Hu L-Y Sun S-F . Risk of osteoporotic fractures as a consequence of haemophilia: A nationwide populationbased cohort study . Haemophilia 2019 ; 25 ( 5 ): 876 - 884 . doi: 10.1111/hae.13814 . Open DOISearch in Google Scholar

32. Gregory WJ, Saygin D. Assessment of physical activity and muscle function in adult inflammatory myopathies. Curr Rheumatol Rep 2022; 24(3): 54-63. doi: 10.1007/s11926-022-01059-5. Gregory WJ Saygin D. Assessment of physical activity and muscle function in adult inflammatory myopathies . Curr Rheumatol Rep 2022 ; 24 ( 3 ): 54 - 63 . doi: 10.1007/s11926-022-01059-5 . Open DOISearch in Google Scholar

33. Ilias I, Milionis C, Zoumakis E. An overview of glucocorticoid-induced osteoporosis. [updated 2022 Mar 19]. In: Feingold KR, Anawalt B, Blackman MR, et al. (eds.). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from https://www.ncbi.nlm.nih.gov/books/NBK278968/ (accessed September 2023). Ilias I Milionis C Zoumakis E. An overview of glucocorticoid-induced osteoporosis . [ updated 2022 Mar 19 ]. In: Feingold KR Anawalt B Blackman MR . (eds.). Endotext [Internet]. South Dartmouth (MA) : MDText.com, Inc .; 2000 -. Available from https://www.ncbi.nlm.nih.gov/books/NBK278968/ ( accessed September 2023 ). Search in Google Scholar

34. Chambers H, Gregory W, McCrum C, et al. Rheumatology Physiotherapy Capabilities Framework: Screening, assessment and specialist management. 2021. Available from https://www.rheumatology.org.uk/Portals/0/Documents/Policy/Rheumatology-physiotherapy-capabilities-framework.pdf?ver=2021-09-24-100925-060 (accessed November 2023). Chambers H Gregory W McCrum C . Rheumatology Physiotherapy Capabilities Framework: Screening, assessment and specialist management . 2021 . Available from https://www.rheumatology.org.uk/Portals/0/Documents/Policy/Rheumatology-physiotherapy-capabilities-framework.pdf?ver=2021-09-24-100925-060 ( accessed November 2023 ). Search in Google Scholar

35. Brooke-Wavell K, Skelton DA, Barker KL, et al. Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis. Br J Sports Med 2022; 56(15): 837-846. doi: 10.1136/bjsports-2021-104634. Brooke-Wavell K Skelton DA Barker KL . Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis . Br J Sports Med 2022 ; 56 ( 15 ): 837 - 846 . doi: 10.1136/bjsports-2021-104634 . Open DOISearch in Google Scholar

36. Featherston R, Downie LE, Vogel AP, Galvin KL. Decision making biases in the allied health care professions: A systematic scoping review. PLoS One 2020; 15(10): e0240716. doi: 10.1371/journal.pone.0240716. Featherston R Downie LE Vogel AP Galvin KL. Decision making biases in the allied health care professions: A systematic scoping review . PLoS One 2020 ; 15 ( 10 ) : e0240716. doi: 10.1371/journal.pone.0240716 . Open DOISearch in Google Scholar

37. Coulter A, Collins A. Making shared decision-making a reality: No decision about me, without me. London: The King’s Fund; 2011. Available from https://www.kingsfund.org.uk/publications/making-shared-decision-making-reality (accessed September 2023). Coulter A Collins A. Making shared decision-making a reality: No decision about me, without me . London : The King’s Fund ; 2011 . Available from https://www.kingsfund.org.uk/publications/making-shared-decision-making-reality ( accessed September 2023 ). Search in Google Scholar

38. Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ 2017; 359: j4891. doi: 10.1136/bmj.j4891. Elwyn G Durand MA Song J . A three-talk model for shared decision making: multistage consultation process . BMJ 2017 ; 359 : j4891. doi: 10.1136/bmj.j4891 . Open DOISearch in Google Scholar

39. World Federation of Hemophilia. WFH shared decision making tool for hemophilia treatment. 2023. Available from https://elearning.wfh.org/resource/wfh-shared-decision-making-tool-for-hemophilia-treatment/#information (accessed September 2023). World Federation of Hemophilia . WFH shared decision making tool for hemophilia treatment . 2023 . Available from https://elearning.wfh.org/resource/wfh-shared-decision-making-tool-for-hemophilia-treatment/#information ( accessed September 2023 ). Search in Google Scholar